Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Modulating the cAMP Efflux.

Carozzo A, Yaneff A, Gómez N, Di Siervi N, Sahores A, Diez F, Attorresi AI, Rodríguez-González Á, Monczor F, Fernández N, Abba M, Shayo C, Davio C.

Mol Pharmacol. 2019 Jul;96(1):13-25. doi: 10.1124/mol.118.115444. Epub 2019 May 1.

PMID:
31043460
2.

A Model of Glucocorticoid Receptor Interaction With Coregulators Predicts Transcriptional Regulation of Target Genes.

Monczor F, Chatzopoulou A, Zappia CD, Houtman R, Meijer OC, Fitzsimons CP.

Front Pharmacol. 2019 Mar 13;10:214. doi: 10.3389/fphar.2019.00214. eCollection 2019.

3.

Participation of Gαi-Adenylate Cyclase and ERK1/2 in Mas Receptor Signaling Pathways.

Burghi V, Echeverría EB, Sosa MH, Quiroga DT, Muñoz MC, Davio C, Monczor F, Fernández NC, Dominici FP.

Front Pharmacol. 2019 Feb 22;10:146. doi: 10.3389/fphar.2019.00146. eCollection 2019.

4.

Involvement of histamine H1 and H2 receptor inverse agonists in receptor's crossregulation.

Díaz Nebreda A, Zappia CD, Rodríguez González A, Sahores A, Sosa M, Burghi V, Monczor F, Davio C, Fernández N, Shayo C.

Eur J Pharmacol. 2019 Mar 15;847:42-52. doi: 10.1016/j.ejphar.2019.01.026. Epub 2019 Jan 24.

PMID:
30685431
5.

Effects of the pesticide chlorpyrifos on breast cancer disease. Implication of epigenetic mechanisms.

Ventura C, Zappia CD, Lasagna M, Pavicic W, Richard S, Bolzan AD, Monczor F, Núñez M, Cocca C.

J Steroid Biochem Mol Biol. 2019 Feb;186:96-104. doi: 10.1016/j.jsbmb.2018.09.021. Epub 2018 Oct 2.

PMID:
30290214
6.

Effect of mutation of Phe 2436.44 of the histamine H2 receptor on cimetidine and ranitidine mechanism of action.

Granja-Galeano G, Zappia CD, Fabián L, Davio C, Shayo C, Fernández N, Monczor F.

Biochem Pharmacol. 2017 Dec 15;146:117-126. doi: 10.1016/j.bcp.2017.09.014. Epub 2017 Sep 28.

PMID:
28962836
8.

Histamine H2 Receptor in Blood Cells: A Suitable Target for the Treatment of Acute Myeloid Leukemia.

Monczor F, Copsel S, Fernandez N, Davio C, Shayo C.

Handb Exp Pharmacol. 2017;241:141-160. doi: 10.1007/164_2016_8. Review.

PMID:
27316911
9.

PI3K pathway is involved in ERK signaling cascade activation by histamine H2R agonist in HEK293T cells.

Alonso N, Diaz Nebreda A, Monczor F, Gutkind JS, Davio C, Fernandez N, Shayo C.

Biochim Biophys Acta. 2016 Sep;1860(9):1998-2007. doi: 10.1016/j.bbagen.2016.06.016. Epub 2016 Jun 15.

PMID:
27316323
10.

Effects of histamine H1 receptor signaling on glucocorticoid receptor activity. Role of canonical and non-canonical pathways.

Zappia CD, Granja-Galeano G, Fernández N, Shayo C, Davio C, Fitzsimons CP, Monczor F.

Sci Rep. 2015 Dec 4;5:17476. doi: 10.1038/srep17476.

11.

Physiological implications of biased signaling at histamine H2 receptors.

Alonso N, Zappia CD, Cabrera M, Davio CA, Shayo C, Monczor F, Fernández NC.

Front Pharmacol. 2015 Mar 10;6:45. doi: 10.3389/fphar.2015.00045. eCollection 2015.

12.

Signal transduction mechanism of biased ligands at histamine H2 receptors.

Alonso N, Monczor F, Echeverría E, Davio C, Shayo C, Fernández N.

Biochem J. 2014 Apr 1;459(1):117-26. doi: 10.1042/BJ20131226.

PMID:
24417223
13.

Antihistaminergics and inverse agonism: potential therapeutic applications.

Monczor F, Fernandez N, Fitzsimons CP, Shayo C, Davio C.

Eur J Pharmacol. 2013 Sep 5;715(1-3):26-32. doi: 10.1016/j.ejphar.2013.06.027. Epub 2013 Jul 4. Review.

PMID:
23831018
14.

Cross-desensitization and cointernalization of H1 and H2 histamine receptors reveal new insights into histamine signal integration.

Alonso N, Fernandez N, Notcovich C, Monczor F, Simaan M, Baldi A, Gutkind JS, Davio C, Shayo C.

Mol Pharmacol. 2013 May;83(5):1087-98. doi: 10.1124/mol.112.083394. Epub 2013 Mar 5.

15.

Roles of phosphorylation-dependent and -independent mechanisms in the regulation of histamine H2 receptor by G protein-coupled receptor kinase 2.

Fernandez N, Gottardo FL, Alonso MN, Monczor F, Shayo C, Davio C.

J Biol Chem. 2011 Aug 19;286(33):28697-706. doi: 10.1074/jbc.M111.269613. Epub 2011 Jun 24.

16.

Measurement of inverse agonism in β-adrenoceptors.

Taira CA, Monczor F, Höcht C.

Methods Enzymol. 2010;485:37-60. doi: 10.1016/B978-0-12-381296-4.00003-8.

PMID:
21050910
17.

Expression of a G protein-coupled receptor (GPCR) leads to attenuation of signaling by other GPCRs: experimental evidence for a spontaneous GPCR constitutive inactive form.

Tubio MR, Fernandez N, Fitzsimons CP, Copsel S, Santiago S, Shayo C, Davio C, Monczor F.

J Biol Chem. 2010 May 14;285(20):14990-8. doi: 10.1074/jbc.M109.099689. Epub 2010 Mar 18.

18.

Coumarins: old compounds with novel promising therapeutic perspectives.

Riveiro ME, De Kimpe N, Moglioni A, Vázquez R, Monczor F, Shayo C, Davio C.

Curr Med Chem. 2010;17(13):1325-38. Review.

PMID:
20166938
19.

Histamine H2 receptor trafficking: role of arrestin, dynamin, and clathrin in histamine H2 receptor internalization.

Fernandez N, Monczor F, Baldi A, Davio C, Shayo C.

Mol Pharmacol. 2008 Oct;74(4):1109-18. doi: 10.1124/mol.108.045336. Epub 2008 Jul 10.

PMID:
18617631
20.

Regulatory mechanisms underlying GKR2 levels in U937 cells: evidence for GRK3 involvement.

Fernandez N, Monczor F, Tubio MR, Shayo C, Davio C.

Biochem Pharmacol. 2007 Jun 1;73(11):1758-67. Epub 2007 Jan 18.

PMID:
17433264
21.
22.

Histamine H2 receptor overexpression induces U937 cell differentiation despite triggered mechanisms to attenuate cAMP signalling.

Monczor F, Fernandez N, Riveiro E, Mladovan A, Baldi A, Shayo C, Davio C.

Biochem Pharmacol. 2006 Apr 14;71(8):1219-28. Epub 2006 Feb 3.

PMID:
16458858
23.

Mepyramine, a histamine H1 receptor inverse agonist, binds preferentially to a G protein-coupled form of the receptor and sequesters G protein.

Fitzsimons CP, Monczor F, Fernández N, Shayo C, Davio C.

J Biol Chem. 2004 Aug 13;279(33):34431-9. Epub 2004 Jun 10.

24.

Induction of cell differentiation in human leukemia U-937 cells by 5-oxygenated-6,7-methylenedioxycoumarins from Pterocaulon polystachyum.

Riveiro ME, Shayo C, Monczor F, Fernández N, Baldi A, De Kimpe N, Rossi J, Debenedetti S, Davio C.

Cancer Lett. 2004 Jul 16;210(2):179-88.

PMID:
15183533
25.

The time-course of cyclic AMP signaling is critical for leukemia U-937 cell differentiation.

Shayo C, Legnazzi BL, Monczor F, Fernández N, Riveiro ME, Baldi A, Davio C.

Biochem Biophys Res Commun. 2004 Feb 13;314(3):798-804.

PMID:
14741706
26.
27.

Reduction of G protein-coupled receptor kinase 2 expression in U-937 cells attenuates H2 histamine receptor desensitization and induces cell maturation.

Fernández N, Monczor F, Lemos B, Notcovich C, Baldi A, Davio C, Shayo C.

Mol Pharmacol. 2002 Dec;62(6):1506-14.

PMID:
12435819
28.

H1 and H2 histamine receptors mediate the production of inositol phosphates but not cAMP in human breast epithelial cells.

Davio C, Mladovan A, Lemos B, Monczor F, Shayo C, Rivera E, Baldi A.

Inflamm Res. 2002 Jan;51(1):1-7.

PMID:
11845995
29.

Histamine H2 receptor desensitization: involvement of a select array of G protein-coupled receptor kinases.

Shayo C, Fernandez N, Legnazzi BL, Monczor F, Mladovan A, Baldi A, Davio C.

Mol Pharmacol. 2001 Nov;60(5):1049-56.

PMID:
11641433
30.

Rapid desensitization and slow recovery of the cyclic AMP response mediated by histamine H(2) receptors in the U937 cell line.

Lemos Legnazzi B, Shayo C, Monczor F, Martin ME, Fernandez N, Brodsky A, Baldi A, Davio C.

Biochem Pharmacol. 2000 Jul 15;60(2):159-66.

PMID:
10825460
31.

Tiotidine, a classical H2-antagonist, presents characteristics of an inverse agonist in U937 cell line.

Monczor F, Legnazzi BL, Rivera E, Davio C.

Inflamm Res. 1998;47 Suppl 1:S42-3. No abstract available.

PMID:
9561408
32.

Histamine receptors in human epithelial cells--characterization of the receptor G-protein-effector system.

Legnazzi BL, Monczor F, Rivera E, Bergoc R, Davio C.

Inflamm Res. 1998;47 Suppl 1:S40-1. No abstract available.

PMID:
9561407

Supplemental Content

Loading ...
Support Center